Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 460: 114829, 2024 Mar 05.
Article in English | MEDLINE | ID: mdl-38141784

ABSTRACT

Major depressive disorder is the most common psychiatric disorder worldwide. To understand mechanisms and search for new approaches to treating depression, animal models are crucial. Chronic mild stress (CMS) is the most used animal model of depression. Although CMS is considered a robust model of depression, conflicting results have been reported for emotion-related behaviors, which the intrinsic characteristics of each rodent strain could explain. To further shed light on the impact of genetic background on the relevant parameters commonly addressed in depression, we examined the effect of 4-weeks CMS on anxiety and depression-related behaviors and body weight gain in three strain mice (BALB/c, C57BL/6, and CD1) of both sexes. CMS reduced body weight gain in C57BL/6NCrl and CD1 male mice. C57BL/6 animals exhibited a more pronounced anxious-like behavior than CD1 and BALB/c mice in the light-dark box (LDB) and the elevated plus maze (EPM) tests, whereas BALB/c animals exhibited the more robust depressive-like phenotype in the splash test (ST), tail suspension test (TST) and forced-swimming test (FST). Under CMS, exposure did not affect anxiety-related behaviors in any strain but induced depression-like behaviors strain-dependently. CMS C57BL/6 and CD1 mice of both sexes showed depression-like behaviors, and CMS BALB/c male mice exhibited reduced depressive behaviors in the FST. These results suggest a differential effect of stress, with the C57BL/6 strain being more vulnerable to stress than the CD1 and BALB/c strain mice. Furthermore, our findings emphasize the need for researchers to consider mouse strains and behavioral tests in their CMS experimental designs.


Subject(s)
Depressive Disorder, Major , Humans , Male , Female , Mice , Animals , Mice, Inbred C57BL , Anxiety/genetics , Swimming , Depression/genetics , Behavior, Animal , Body Weight , Stress, Psychological , Disease Models, Animal
2.
Dev Psychobiol ; 65(1): e22357, 2023 01.
Article in English | MEDLINE | ID: mdl-36567650

ABSTRACT

Animal models are crucial to understanding the mechanisms underlying the deleterious consequences of early-life stress. Here, we aimed to examine the effect of the limited bedding nesting (LBN) paradigm on early life development milestones and anxiety- and/or depression-like behavior in adolescent and adult mice from two inbred mice of both sexes. C57BL/6NCrl and BALB/c litters were exposed to the LBN paradigm postnatal day (PND) 2-9. Maternal behavior recording occurred on PND 3-9, and pups were weighed daily and examined to verify the eye-opening on PND 10-22. The male and female offspring underwent evaluation in the open field test, elevated plus-maze, and the forced swimming test during adolescence (PND 45-49) and adulthood (PND 75-79). We found that LBN impaired the maternal behavior patterns of both strain dams, mainly on C57BL/6NCrl strain. Also, LBN delayed the pup's eye-opening time and reduced body weight gain, impacting C57BL/6NCrl pups more. We also found that LBN decreased anxiety-related indices in adolescent and adult male but not female mice of both strains. Furthermore, LBN decreased depression-related indices only adolescent female and male BALB/c and female but not male C57BL/6NCrl mice. These findings reinforce the evidence that the LBN paradigm impairs the maternal behavior pattern and pup's early developmental milestones but does not induce anxiety- or depressive-like behavior outcomes during later life.


Subject(s)
Anxiety Disorders , Anxiety , Male , Humans , Female , Animals , Mice , Mice, Inbred C57BL , Maternal Behavior , Bedding and Linens , Behavior, Animal
3.
Neurobiol Aging ; 34(8): 2071-6, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23473707

ABSTRACT

Alzheimer's disease (AD) is a progressive, neurodegenerative brain disorder characterized by extracellular accumulations of amyloid ß (Aß) peptides, intracellular accumulation of abnormal proteins, and early loss of basal forebrain neurons. Recent studies have indicated that the conformation of Aß is crucial for neuronal toxicity, with intermediate misfolded forms such as oligomers being more toxic than the final fibrillar forms. Our previous work shows that Aß blocks the potassium (K(+)) currents IM and IA in septal neurons, increasing firing rates, diminishing rhythmicity and firing coherence. Evidence also suggests that oxidative stress (OS) plays a role in AD pathogenesis. Thus we wished to determine the effect of oligomeric and fibrillar forms of Aß1₋42 on septohippocampal damage, oxidative damage, and dysfunction in AD. Oligomeric and fibrillar forms of Aß1₋42 were injected into the CA1 region of the hippocampus in live rats. The rats were sacrificed 24 hours and 1 month after Aß or sham injection to additionally evaluate the temporal effects. The expression levels of the K(+) voltage-gated channel, KQT-like subfamily, member 2 (KCNQ2) and the OS-related genes superoxide dismutase 1, 8-oxoguanine DNA glycosylase, and monamine oxidase A, were analyzed in the hippocampus, medial, and lateral septum. Our results show that both forms of Aß exhibit time-dependent differential modulation of OS and K(+) channel genes in the analyzed regions. Importantly, we demonstrate that Aß injected into the hippocampus triggered changes in gene expression in anatomical regions distant from the injection site. Thus the Aß effect was transmitted to anatomically separate sites, because of the functional coupling of the brain structures.


Subject(s)
Alzheimer Disease/etiology , Amyloid beta-Peptides/toxicity , DNA Glycosylases/metabolism , Hippocampus/metabolism , KCNQ2 Potassium Channel/metabolism , Monoamine Oxidase/metabolism , Oxidative Stress/genetics , Peptide Fragments/toxicity , Superoxide Dismutase/metabolism , Amyloid beta-Peptides/physiology , Animals , DNA Glycosylases/genetics , Gene Expression/drug effects , Monoamine Oxidase/genetics , Peptide Fragments/physiology , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/genetics , Superoxide Dismutase-1 , Time Factors
4.
Brain Res ; 1368: 308-16, 2011 Jan 12.
Article in English | MEDLINE | ID: mdl-20971086

ABSTRACT

Voltage gated K(+) channels (Kv) are a highly diverse group of channels critical in determining neuronal excitability. Deficits of Kv channel subunit expression and function have been implicated in the pathogenesis of epilepsy. In this study, we investigate whether the expression of the specific subunit Kv3.4 is affected during epileptogenesis following pilocarpine-induced status epilepticus. For this purpose, we used immunohistochemistry, Western blotting assays and comparative analysis of gene expression using TaqMan-based probes and delta-delta cycle threshold (ΔΔCT) method of quantitative real-time polymerase chain reaction (qPCR) technique in samples obtained from age-matched control and epileptic rats. A marked down-regulation of Kv3.4 immunoreactivity was detected in the stratum lucidum and hilus of dentate gyrus in areas corresponding to the mossy fiber system of chronically epileptic rats. Correspondingly, a 20% reduction of Kv3.4 protein levels was detected in the hippocampus of chronic epileptic rats. Real-time quantitative PCR analysis of gene expression revealed that a significant 33% reduction of transcripts for Kv3.4 (gene Kcnc4) occurred after 1 month of pilocarpine-induced status epilepticus and persisted during the chronic phase of the model. These data indicate a reduced expression of Kv3.4 channels at protein and transcript levels in the epileptic hippocampus. Down-regulation of Kv3.4 in mossy fibers may contribute to enhanced presynaptic excitability leading to recurrent seizures in the pilocarpine model of temporal lobe epilepsy.


Subject(s)
Epilepsy/metabolism , Hippocampus/metabolism , Shaw Potassium Channels/metabolism , Animals , Dentate Gyrus/metabolism , Disease Models, Animal , Down-Regulation/drug effects , Epilepsy/chemically induced , Gene Expression/drug effects , Mossy Fibers, Hippocampal/metabolism , Pilocarpine , Rats , Rats, Sprague-Dawley , Shaw Potassium Channels/genetics , Time Factors
5.
Neuroreport ; 19(13): 1291-4, 2008 Aug 27.
Article in English | MEDLINE | ID: mdl-18695509

ABSTRACT

Epileptogenesis in mesial temporal lobe epilepsy is determined by several factors including abnormalities in the expression and function of ion channels. Here, we report a long-lasting deficit in gene expression of Kcnma1 coding for the large-conductance calcium-activated potassium (BK, MaxiK) channel alpha-subunits after pilocarpine-induced status epilepticus. By using comparative real-time PCR, Taqman gene expression assays, and the delta-delta comparative threshold method we detected a significant reduction in Kcnma1 expression in microdissected dentate gyrus at different intervals after status epilepticus (24 h, 10 days, 1 month, and more than 2 months). BK channels are key regulators of neuronal excitability and transmitter release. Hence, defective Kcnma1 expression may play a critical role in the pathogenesis of mesial temporal lobe epilepsy.


Subject(s)
Dentate Gyrus/metabolism , Epilepsy, Temporal Lobe/genetics , Gene Expression Profiling , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/genetics , Analysis of Variance , Animals , Disease Models, Animal , Down-Regulation/drug effects , Gene Expression/drug effects , Injections, Intraperitoneal , Injections, Subcutaneous , Muscarinic Agonists/administration & dosage , Muscarinic Agonists/toxicity , Pilocarpine/administration & dosage , Pilocarpine/toxicity , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction , Seizures/chemically induced , Seizures/genetics , Status Epilepticus/chemically induced , Status Epilepticus/genetics , Time Factors
6.
Brain Res ; 1226: 173-80, 2008 Aug 21.
Article in English | MEDLINE | ID: mdl-18585369

ABSTRACT

Group II metabotropic glutamate (mGlu II) receptors subtype 2 and 3 (mGlu2 and mGlu3) are subtle regulators of neuronal excitability and synaptic plasticity in the hippocampus. In recent years, researchers have investigated the potential neuroprotective and anticonvulsant effects of compounds acting on mGlu II receptors. However, abnormal expression and function of mGlu2 and mGlu3 have been reported in temporal lobe epilepsy, a phenomena that may limit the therapeutic effectiveness of these potentially new antiepileptic drugs. Here, we investigated seizure-induced changes in mGlu2 and mGlu3 mRNA following pilocarpine-inducted status epilepticus (SE) and subsequent epileptogenesis. Relative changes in gene expression were assessed by comparative analysis of quantitative real-time PCR (qrtPCR) by the delta-delta CT method. Pilocarpine-treated and control rats were sacrificed at different periods (24 h, 10 days, one month and more than two months) following SE. Total RNA was isolated from microdissected dentate gyrus and processed for RT-PCR and qrtPCR using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous control gene. Analysis of relative quantification (RQ) ratios of mGlu2 and mGlu3 mRNA expression revealed a significant down-regulation of both targets at 24 h after SE. Gene expression partially recovered at 10 days following SE reaching control levels at one month after SE. Two month after SE, mGlu2 mRNA expression was significantly down-regulated to approximately 41% of control expression whereas mGlu3 mRNA was comparable to control levels. Our data indicate that mGlu2 and mGlu3 expression is dynamically down-regulated or selectively enhanced during critical periods of epileptogenesis. Seizure-induced differential dysregulation of mGlu2 and mGlu3 receptors may affect the availability of these molecular targets for therapeutic compounds in epilepsy.


Subject(s)
Gene Expression Regulation/drug effects , Pilocarpine , Receptors, Metabotropic Glutamate/metabolism , Status Epilepticus/chemically induced , Status Epilepticus/metabolism , Analysis of Variance , Animals , Disease Models, Animal , Pilocarpine/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Metabotropic Glutamate/genetics , Time Factors
7.
Brain Res ; 1200: 116-31, 2008 Mar 20.
Article in English | MEDLINE | ID: mdl-18295190

ABSTRACT

In the hippocampus, BK channels are preferentially localized in presynaptic glutamatergic terminals including mossy fibers where they are thought to play an important role regulating excessive glutamate release during hyperactive states. Large conductance calcium-activated potassium channels (BK, MaxiK, Slo) have recently been implicated in the pathogenesis of genetic epilepsy. However, the role of BK channels in acquired mesial temporal lobe epilepsy (MTLE) remains unknown. Here we used immunohistochemistry, laser scanning confocal microscopy (LSCM), Western immunoblotting and RT-PCR to investigate the expression pattern of the alpha-pore-forming subunit of BK channels in the hippocampus and cortex of chronically epileptic rats obtained by the pilocarpine model of MTLE. All epileptic rats experiencing recurrent spontaneous seizures exhibited a significant down-regulation of BK channel immunostaining in the mossy fibers at the hilus and stratum lucidum of the CA3 area. Quantitative analysis of immunofluorescence signals by LSCM revealed a significant 47% reduction in BK channel immunofluorescent signals in epileptic rats when compared to age-matched non-epileptic control rats. These data correlate with a similar reduction in BK channel protein levels and transcripts in the cortex and hippocampus. Our data indicate a seizure-related down-regulation of BK channels in chronically epileptic rats. Further functional assays are necessary to determine whether altered BK channel expression is an acquired channelopathy or a compensatory mechanism affecting the network excitability in MTLE. Moreover, seizure-mediated BK down-regulation may disturb neuronal excitability and presynaptic control at glutamatergic terminals triggering exaggerated glutamate release and seizures.


Subject(s)
Down-Regulation/physiology , Epilepsy, Temporal Lobe/metabolism , Hippocampus/metabolism , Large-Conductance Calcium-Activated Potassium Channels/metabolism , Neurons/metabolism , Animals , Cell Membrane/chemistry , Cell Membrane/drug effects , Cell Membrane/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/physiopathology , Chronic Disease , Convulsants/pharmacology , Disease Models, Animal , Down-Regulation/drug effects , Epilepsy, Temporal Lobe/chemically induced , Epilepsy, Temporal Lobe/physiopathology , Fluorescent Antibody Technique , Genetic Predisposition to Disease/genetics , Hippocampus/drug effects , Hippocampus/physiopathology , Large-Conductance Calcium-Activated Potassium Channels/drug effects , Large-Conductance Calcium-Activated Potassium Channels/genetics , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mossy Fibers, Hippocampal/drug effects , Mossy Fibers, Hippocampal/metabolism , Muscarinic Agonists/pharmacology , Neurons/drug effects , Pilocarpine , Potassium/metabolism , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Vesicular Glutamate Transport Protein 1/drug effects , Vesicular Glutamate Transport Protein 1/metabolism
8.
Brain Res ; 1144: 219-30, 2007 May 04.
Article in English | MEDLINE | ID: mdl-17346683

ABSTRACT

The dipeptide N-acetylaspartylglutamate (NAAG) has been recently implicated in numerous neurological disorders. NAAG binds and stimulates group II metabotropic glutamate receptors producing a down-modulation of synaptic glutamate release. In the present immunohistochemical study, we compare the distribution of NAAG-containing (NAAGergic) neurons between the hippocampus of control and chronic epileptic rats obtained with the pilocarpine model of temporal lobe epilepsy. In the hippocampal formation, NAAGergic neurons comprise a subpopulation of GABAergic neurons. Examination by light microscopy revealed a significant reduction of NAAG-immunoreactive neurons in CA3 stratum oriens (35.8%) and CA1 stratum oriens (78.87%), stratum pyramidale (40%), and stratum radiatum (56.6%). Similar loss of NAAGergic neurons was observed in the subiculum characterized by 71.82% and 77.53% reduction in the stratum oriens and radiatum, respectively, when compared with controls. NAAGergic neurons in CA2 and dentate gyrus were apparently resistant to seizure-related cell loss but appeared more complex and exhibited numerous NAAG-positive puncta. Our findings indicate a selective vulnerability of NAAGergic neurons in temporal lobe epilepsy.


Subject(s)
Dipeptides/metabolism , Epilepsy, Temporal Lobe/pathology , Hippocampus/pathology , Neurons/metabolism , Neurons/pathology , Animals , Cell Count/methods , Cell Survival/drug effects , Cell Survival/physiology , Disease Models, Animal , Epilepsy, Temporal Lobe/chemically induced , Glutamate Decarboxylase/metabolism , Isoenzymes/metabolism , Male , Pilocarpine , Rats , Rats, Sprague-Dawley , Vesicular Glutamate Transport Protein 1/metabolism
9.
Brain Res ; 1098(1): 170-85, 2006 Jul 07.
Article in English | MEDLINE | ID: mdl-16793029

ABSTRACT

Epilepsy is characterized by hyperexcitability of hippocampal networks, excessive release of glutamate, and progressive neurodegeneration. Presynaptic group II metabotropic receptors (mGluR2 and mGluR3) are among different mechanisms that modulate presynaptic release of glutamate, especially at the mossy fibers in the hippocampus. Here, we explore whether mGluR2/3 expression is affected in a rat model of temporal lobe epilepsy obtained via pilocarpine-induced status epilepticus (SE). Immunohistochemical assays were performed in age-matched controls and two groups of epileptic rats sacrificed at 25-35 days (1 month post-SE) and at 55-65 days (2 months post-SE) following SE onset. A dramatic lessening of mGluR2/3 immunofluorescence was observed at CA1 and CA3 stratum lacunosum/molecular (SLM) declining to 60% and 68% of control values in 1-month and 2-month post-SE, respectively. Additionally, thickness of mGluR2/3-stained SLM layer narrowed up to 70% of controls indicating atrophy at this branch of the perforant path. Epileptic rats exhibited a marked and progressive down-regulation of mGluR2/3 expression in mossy fiber at hilus and CA3 stratum lucidum in contrast with an enhanced expression of vesicular glutamate transporter type 1 (VGluT1) at the mossy fibers. Intense VGluT1 punctated staining was detected at the inner third molecular layer indicating glutamatergic sprouting. In the molecular layer, mGluR2/3 labeling slightly declined in the 1-month post-SE group but then increased in the 2-month post-SE group although it was diffusely distributed. Down-regulation of mGluR2/3 at the mossy fibers and the SLM may render epileptic hippocampal networks hyperexcitable and susceptible to glutamate-mediated excitotoxicity and neurodegeneration.


Subject(s)
Epilepsy, Temporal Lobe/genetics , Epilepsy, Temporal Lobe/metabolism , Mossy Fibers, Hippocampal/metabolism , Receptors, Metabotropic Glutamate/biosynthesis , Animals , Chronic Disease , Dentate Gyrus/metabolism , Dentate Gyrus/pathology , Down-Regulation , Epilepsy, Temporal Lobe/chemically induced , Fluorescent Antibody Technique , Immunohistochemistry , Male , Muscarinic Agonists , Pilocarpine , Rats , Rats, Sprague-Dawley , Receptors, Metabotropic Glutamate/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...